The shares of Eckert & Ziegler, a member of the Value Stars Germany Index, ended their downward slide over the course of 2023 and found a bottom. The good prospects for operational business and a change in strategy ensure attractive performance opportunities in the current year.
A column by Holger Steffen, investment expert and advisor for the Value Stars Germany Index.
The price development of our portfolio stock Eckert & Ziegler (EZAG) was still disappointing in 2023. The approach of developing radiodiagnostics ourselves in the future and getting them approved led to a significantly increased cost base – and to uncertainty among many investors. In addition to declining profitability until drug development is successful, there are also risks that are difficult to calculate in the context of approval. In October 2023, management made a U-turn. We welcome the step and see great things […]
